Toggle light / dark theme

Semaglutide slows blood protein signature linked to future dementia risk

A post hoc analysis of 2,970 older SELECT participants found that semaglutide slowed worsening of a 25-protein blood signature that predicts future dementia risk. Over 104 weeks, semaglutide produced larger effects on modeled 5-year than 20-year dementia risk, but whether these biomarker changes translate into less cognitive decline or dementia remains unknown.

A Common Cholesterol Treatment May Also Remove PFAS And Microplastics From Blood

A filter used to clear excess fats from the blood of people with cardiovascular disease may also trap much smaller stowaways: some persistent synthetic chemicals and microplastics.

The treatment, known as therapeutic apheresis, passes a patient’s blood through a machine, filters out targeted substances, and returns the blood to the body.

It was not developed to remove environmental pollutants. It is generally used in severe cases where medication alone cannot sufficiently remove cholesterol – fat-carrying particles linked to cardiovascular disease risk.

Could the Next Brain Interface Get Sprayed Up Your Nose?

A brain computer interface (BCI) is any technology that allows you to connect your 3 pounds of wetware to a computer. But instead of implanting electrodes via neurosurgery, might the next revolution in BCIs come from something very small, like nanoparticles? Would this allow us to spy on millions (or billions) of neurons talking at once — and could we do so without opening the skull? Will this allow BCI tech to become as common as smartphones? Join Eagleman as he talks with Tetiana Aleksandrova and Scott Meek from the company Subsense about why the next brain-computer interface might come from thinking small.

Subscribe for new episodes weekly. 🛎

INNER COSMOS PODCAST: Stanford neuroscientist David Eagleman tackles wild questions that illuminate new facets of our lives.
❤️ iHeartRadio: ihr.fm/3TxDAqb.
🍎 Apple podcasts: apple.co/3LTxTkH
📢 Amazon Music: amzn.to/3ZxGM6R
🟢 Spotify: spoti.fi/3lOaXZl.

X.com/davideagleman.
instagram.com/davideagleman.
fb.com/david.m.eagleman.
linkedin.com/in/davideagleman.

#Eagleman #InnerCosmos #Science #Neuroscience

PlasmidGPT: A generative framework for plasmid analysis and generation

By training an AI model using 153,208 plasmids from Addgene, Shao et al.’s PlasmidGPT can annotate and classify existing plasmids as well as generate new functional plasmid sequences from DNA “prompts”. While existing plasmid design tools currently surpass PlasmidGPT in sophistication, future architecture and training data augmentations may allow us to automate much of the plasmid design process. I could certainly see this playing a role in high-throughput biological screening methods.


Assembly standards facilitate the construction of functional plasmids (13). Collections such SEVA (14, 15) and CIDAR MoClo (16) include ready-to-use constructs and genetic parts that can be easily assembled, making them valuable tools for microorganism bioengineering and genome editing. Tools such as Cello (17, 18) can design genetic constructs with a high success rate for specific functions, such as computation, across diverse organisms. iBioSim 3 enables the design and modeling of genetic circuits that extend beyond logic circuits (19). However, there is still no computational method capable of harnessing the existing collection of plasmid sequences for designing the full spectrum of plasmids, such as those for mammalian expression, bacterial expression, and gateway vectors. Consequently, for many applications, plasmid DNA design remains a labor-intense process that requires manual inspection, annotation, and the combination of functional sequences.

Recently, generative models such generative pretrained transformers (GPTs) (20) have demonstrated remarkable success in modeling human language. Given the similarity of human language and biological sequences such as protein and DNA, researchers have adapted these frameworks to design proteins (21) and, more recently, to generate genomic sequences that contain potentially functional regulatory elements and genes (2224). Despite these advances, it remains an open question whether language models can be leveraged to efficiently design and analyze complex engineered DNA.

Here, we introduce PlasmidGPT, a generative framework for designing and annotating plasmid DNA sequences (Fig. 1A). Our framework is built on a decoder-only transformer model that is pretrained on 153,208 plasmid sequences from Addgene (25), a public repository for engineered DNA sequences. We demonstrate that sequence embeddings generated by PlasmidGPT encode plasmid sequences into a continuous numerical space. These sequence representations facilitate the visualization of research topics across laboratories by capturing sequence-level similarities and variations. Leveraging simple machine learning models trained on these embeddings, PlasmidGPT enables the fast identification of a wide range of high-level plasmid features (vector type, selectable marker, growth strain, and lab of origin) directly from sequence, facilitating plasmid analysis tasks such as functional annotation and provenance tracking. Moreover, PlasmidGPT generates plasmids that have genetic part distributions similar to those of the training sequences. Conditional plasmid generation can be achieved either by providing a user-specified starting sequence or by fine-tuning the model using special tokens that represent specific vector types. Furthermore, we experimentally validated the functionality of two model-generated plasmids in bacterial cells.

First complete songbird genome exposes missing genes and chromosome architecture

The zebra finch is one of the best-studied songbirds and a model for understanding the biology and neuroscience of vocal learning. Now, researchers have produced the first complete genome assembly of the species, revealing thousands of previously hidden genes and chromosome structures.

Protein ‘switch’ determines whether liposarcoma cells will become aggressive

New research from an expert in cancer biology explains what triggers liposarcoma cells to become more or less aggressive and identifies potential targets that could keep aggressive tumors in check. A study led by Blake Wilde, Ph.D., of Roswell Park Comprehensive Cancer Center highlights how this discovery may pave the way for new treatment options for this cancer.

The findings are published in the journal Science Advances.

More than half of all people with liposarcoma will see their cancer return after treatment, underscoring the need for new and better treatment options. The two most common types of this cancer, which begins in fat tissue, are well-differentiated (WD) and dedifferentiated (DD) liposarcoma, explains the study’s first author, Blake Wilde, Ph.D., assistant professor of oncology in the Departments of Urology and Cell Stress Biology at Roswell Park.

Solving a mysterious inflammatory fever opens the book on a much bigger story

Three research teams working independently around the world have landed on the same discovery: A single molecular “handshake” inside our cells controls a family of inflammatory diseases, including one of the most common inherited fevers on Earth. The finding solved a decades-old puzzle for one family and led to a treatment that worked almost immediately.

It all revolves around Familial Mediterranean Fever (FMF), the most common inherited autoinflammatory disease, which affects an estimated 1–2 in every 1,000 people in high-prevalence populations, including those of Mediterranean, Middle Eastern, Armenian and Jewish ancestry. FMF begins in childhood, causing recurring fevers, painful rashes and joint pain.

For more than 20 years, one family lived with a mysterious illness that resembled FMF, but nothing doctors tried would cure it.

/* */